Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation method of recombinant human oligoadenylate synthetase-1

A technology of chemical synthesis and recombinant engineering bacteria, applied in the direction of transferase, etc., can solve the problems of complex steps, low process yield, limited improvement of OAS1 protein purity, etc.

Active Publication Date: 2013-02-13
BEIJING TRI PRIME GENE PHARMA CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] Chinese patent application 200780035985.X discloses a method for expressing OAS protein and its mutants using a prokaryotic inclusion body expression system and purifying the expressed OAS protein and its mutants. Although the OAS protein can be expressed and purified without using tags, due to The renaturation process can only increase the purity of OAS1 protein to a limited extent, so at least two steps of chromatography are required in the subsequent chromatographic purification, such as heparin column chromatography first, and then Phenyl FF HP chromatography
The result of such expression and purification is that the steps are still complicated and the yield of the whole process is low

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of recombinant human oligoadenylate synthetase-1
  • Preparation method of recombinant human oligoadenylate synthetase-1
  • Preparation method of recombinant human oligoadenylate synthetase-1

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Embodiment 1: Construction of expression vector

[0036] The pBluescript II SK(+)-OAS1 synthesized by Shanghai Sangon Bioengineering Technology Service Co., Ltd. was digested with Nde I and EcoRI, and the digested product was subjected to 1% agarose gel electrophoresis. The results were as follows: figure 1 shown. The target gene was recovered with Agarose Gel DNA Purification Kit, and then ligated with the expression vector pET23b(+) that had undergone the same digestion. The ligation reaction conditions were: 10x T4 buffer 2 μl, T4 DNA Ligase 1 μl, target fragment 5 μl, vector 12 μl, overnight at 16°C connect. Thus, the pET23b(+)-OAS1 recombinant plasmid was constructed. The recombinant plasmid was identified by agarose gel electrophoresis after double digestion with Nde I and EcoRI. figure 2 shown.

Embodiment 2

[0037] Example 2: Transformation and screening of competent Escherichia coli BL21(DE3)pLys

[0038] Add 1-2ng of the supercoiled recombinant plasmid pET23b(+)-OAS1 into 100μl Escherichia coli BL21(DE3)pLys competent cells, swirl gently to mix well, let stand in ice bath for 30s, heat shock at 42°C for 60-90s, and put in ice bath Let stand and cool for 2-3min, add 900μl LB medium (without antibiotics), culture with shaking at 37℃ for 45min, pipette 100μl after mixing and spread on LB plate (containing 1μg / ml ampicillin sodium), incubate upside down at 37℃ for 12- 16h.

[0039] A single colony was picked for culture, and the clones identified as positive by enzyme digestion and expression detection were automatically sequenced by the ABI377 sequencer with T7 universal primers, and the sequencing results were consistent with the theoretical sequence.

Embodiment 3

[0040] Example 3: LB medium fermentation culture of OAS1 and acquisition of inclusion bodies

[0041] After the positive engineered bacteria obtained by screening were activated by spreading on the plate, a single colony was selected and inoculated in LB medium containing ampicillin (prepared with 10 g of peptone, 5 g of yeast powder, and 10 g of NaCl per liter, and the pH was adjusted to 7.0), at 37 ° C, 220 R / min Shaker Flask Culture to OD 600nm Reach 0.6-0.8. Then inoculate in the LB culture medium of 50L with 5% volume inoculum amount, carry out fermentation culture (every liter contains the ampicillin of 0.1%) in 80L fermenter, culture temperature is 37 ℃, regulates pH with ammonia water in the cultivation process Between 6.5-7.5, the dissolved oxygen value is controlled between 3-5% by adjusting the stirring speed. in OD 600nm After reaching 1.0, 10 g of IPTG was added at a mass volume ratio of 1:5000 to continue the induction culture for 3 hours. The induction cultur...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of biological medicine, and relates to a preparation method of recombinant human oligoadenylate synthetase-1 (OAS1), which comprises the following steps in order: 1) chemically synthesizing an OAS1 protein gene expression sequence; 2) constructing recombinant engineering bacteria which express the OAS1 protein; 3) performing fermentation culture to generate OAS1 expressed in a form of an inclusion body; 4) obtaining the inclusion body, washing the inclusion body orderly with solutions that contain urea with concentrations, from low to high, of 1-8 mol / L, wherein the inclusion body is washed once by each solution with one urea concentration, and is washed for 2-4 times totally, performing denaturalization treatment by a solution containing 6-8 mol / L of guanidine hydrochloride and a same buffer solution system as that used in cation exchange chromatography in the next step; 5) performing purification treatment of the denaturalized solution by a cation exchange chromatography column, and eluting to obtain the OAS1 denatured protein with a purity of above 95%. The method can purify the OAS1 protein expressed by a prokaryotic expression system in one step without the addition of tags which facilitate purification; the purity of the OAS1 protein is up to above 95%, which better meets the requirements for immunization and antibody screening.

Description

technical field [0001] The present invention generally relates to a preparation method of recombinant human oligoadenylate synthetase, and particularly relates to a preparation method of recombinant human oligoadenylate synthase-1. Background technique [0002] Chronic viral hepatitis (HBV) is a major global disease, and 500,000 to 1,200,000 people die from the disease and the liver cirrhosis and liver cancer caused by it every year. As a first-line drug, although interferon α (interferon α, IFN α ) has dual functions of antiviral and immune regulation in the treatment of HBV, only 25%-50% of HBV patients are treated clinically with IFN α. Therefore, how to predict the curative effect of IFNα in the treatment of HBV through the principle of IFNα in the early stage, so as to determine the suitable target of IFNα for the treatment of HBV patients, and correctly guide the clinical medication is very critical. [0003] 2', -5' oligoadenylate synthetase (2', 5'-Oligoadenylate sy...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N9/12
Inventor 周敏毅李孜徐晨刘金毅程永庆
Owner BEIJING TRI PRIME GENE PHARMA CO LTD